Clinical trial
Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in…
NCT00372255 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00372255 |
|---|---|
| Title | Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years |
| Official title | An Open, Phase IV Study on the Immunogenicity and Tolerability of Influsplit SSW® 2005/2006 in Children Aged 6 - 13 Years |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Influenza |
| Intervention type | Biological |
| Interventions | Influsplit SSW® 2005/2006 |
| Enrollment | 240 |
| Start date | Nov 17, 2005 |
| Primary completion | Mar 28, 2006 |
| Completion | Mar 28, 2006 |
| First posted | Sep 6, 2006 |
| Last update posted | May 6, 2019 |
| Countries | Germany |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: